Work status and return to work after treatment for bladder, prostate, and kidney cancers and urinary stones

Occupational Situation of Patients With Urological Diseases and Return to Work in Patients Undergoing Major Uro-Oncological Operations and Procedures for Urinary Tract Stones

Jagiellonian University · NCT07088536

This project will test how treatment for bladder, prostate, or kidney cancer and procedures for urinary stones affect whether adult patients can return to work and their quality of life.

Quick facts

Study typeObservational
Enrollment2000 (estimated)
Ages18 Years and up
SexAll
SponsorJagiellonian University (other)
Locations1 site (Krakow, Malopolska)
Trial IDNCT07088536 on ClinicalTrials.gov

What this trial studies

Over a six-month period at Jagiellonian University Medical College in Kraków, all adult urology admissions will complete a baseline survey about their occupational situation. A prospective subgroup of employed patients undergoing major uro-oncological surgeries or procedures for urinary stones will also complete quality-of-life questionnaires and receive phone follow-up at 3 and 6 months. The study combines a cross-sectional baseline capture with short-term longitudinal follow-up to track return-to-work outcomes and changes in well-being. Results will be used to identify barriers to returning to work and inform support and rehabilitation strategies for urological patients.

Who should consider this trial

Good fit: Ideal candidates are adults (≥18) admitted to the Department of Urology at Jagiellonian University Medical College during the six-month enrollment who are employed and undergoing major uro-oncological surgery or a urinary stone procedure for the prospective follow-up, while all admitted adults are eligible for the baseline survey.

Not a fit: Patients who are unemployed, retired, not undergoing major uro-oncological surgery or stone procedures, or treated outside the Kraków center are unlikely to receive direct benefit from the prospective follow-up data.

Why it matters

Potential benefit: If successful, the findings could help hospitals design targeted support and rehabilitation to improve return-to-work rates and quality of life for urology patients.

How similar studies have performed: Previous cancer survivorship studies using questionnaires and short-term follow-up have identified return-to-work barriers and informed rehabilitation programs, but focused, systematic data specific to major urological surgeries are relatively limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult patients (≥18 years) admitted to the Department of Urology and Oncological Urology, University Hospital in Kraków, during the 6-month study period.
2. For the prospective follow-up cohort:

   1. Occupationally active (employed) at baseline.
   2. Undergoing major uro-oncological surgery (e.g., radical cystectomy, radical prostatectomy, nephrectomy) or a procedure for urinary tract stones (e.g., ureterorenoscopy, percutaneous nephrolithotripsy).
3. Able and willing to provide written informed consent.

Exclusion Criteria:

1. Patients unwilling or unable to provide informed consent.
2. Patients who are unemployed or retired at baseline (excluded from the prospective follow-up cohort but included in the baseline cross-sectional survey).
3. Patients not undergoing major uro-oncological surgery or urinary tract stone procedures (for the prospective follow-up cohort).

Where this trial is running

Krakow, Malopolska

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Bladder Cancer, Prostate Cancer, Renal Cancer, Urinary Stones

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.